Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Sarcoma, Endometrial Stromal × trebananib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Sarcoma, Endometrial Stromal 1

Interventions

Radiotherapy 2 Ifosfamide 2 Filgrastim 2 Doxorubicin 2 trebananib 1 perifosine 1 Trabectedin 1 Mass Spectrometry 1 Imatinib Mesylate 1 Chromatography, High Pressure Liquid 1 Chemotherapy, Adjuvant 1 BI 2536 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01210222 2018-02-23

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

GOG Foundation

Phase 2 Completed

35 enrolled 9 charts

GynecologicSarcoma

Sarcoma, Endometrial Stromal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡